|
GSK3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.063900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.104100E-02 |
| Normal-vs-Stage2 |
6.112800E-01 |
| Normal-vs-Stage3 |
2.511800E-02 |
| Normal-vs-Stage4 |
3.553000E-01 |
| Stage1-vs-Stage2 |
1.706570E-01 |
| Stage1-vs-Stage3 |
6.249600E-01 |
| Stage1-vs-Stage4 |
2.798800E-01 |
| Stage2-vs-Stage3 |
1.608770E-01 |
| Stage2-vs-Stage4 |
7.716200E-01 |
| Stage3-vs-Stage4 |
1.702240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.416100E-02 |
| Normal-vs-AfricanAmerican |
8.957200E-01 |
| Normal-vs-Asian |
1.190610E-01 |
| Caucasian-vs-AfricanAmerican |
2.206000E-01 |
| Caucasian-vs-Asian |
7.565600E-01 |
| AfricanAmerican-vs-Asian |
2.486800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.385200E-01 |
| Normal-vs-Female |
2.296400E-02 |
| Male-vs-Female |
2.634600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.429550E-02 |
| Normal-vs-Age(41-60Yrs) |
6.479500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.385760E-01 |
| Normal-vs-Age(81-100Yrs) |
8.526400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.963800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.939200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.651600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.006400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.074200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.600400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.285760E-02 |
| Classical-VS-Follicular |
9.669600E-01 |
| Classical-VS-Other |
6.320800E-01 |
| Classical-VS-Normal |
1.101400E-01 |
| Tall-VS-Follicular |
5.182300E-02 |
| Tall-VS-Other |
5.123800E-01 |
| Tall-VS-Normal |
2.283100E-03 |
| Follicular-VS-Other |
7.158600E-01 |
| Follicular-VS-Normal |
1.891980E-01 |
| Other-VS-Normal |
2.491000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.035440E-01 |
| Normal-vs-N1 |
7.280200E-03 |
| N0-vs-N1 |
1.279650E-01 |
|
|
